High-risk patients with negative findings at low-dose CT lung cancer screening are still at a high risk of developing lung cancer later in life, according to a new study published in Radiology. The authors added that screening should continue after more than three years.

After a recent JAMA Oncology study suggested around a third of women might benefit from avoiding breast cancer screening altogether, one Guardian editorialist is warning women of the psychological toll that can come hand-in-hand with genetic screening.

The Radiology Coding Certification Board (RCCB), a nonprofit radiology credentialing organization, announced this week that it has introduced a new credential for coders proficient in interventional radiology coding.

CMS has announced participants in the Bundled Payment for Care Improvement (BPCI) Advanced model will be able to retroactively withdraw beginning in March 2019.

President Donald Trump lashed out at drug manufacturer Pfizer after the company raised prices for 100 drugs by an average of 9 percent, effective July 1.

Men who suffer from benign prostatic hyperplasia have a new treatment option, University of California, San Diego researchers announced this July—and it’s one that involves minimal operative pain, fewer out-of-pocket dollars and no hospital stay.

Radiology Partners has announced a new partnership with West Houston Radiology in Houston.

National Cancer Institute-designated websites publish lower-quality information about prostate cancer screenings than sites run by major allied organizations like the Centers for Disease Control and Prevention or the Prostate Cancer Foundation, according to a report published this month in Practical Radiation Oncology.